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Emergence of the Extended-Spectrum -Lactamase GES-1 in a Pseudomonas
aeruginosa Strain from Brazil: Report from the SENTRY Antimicrobial
Surveillance Program
The extended-spectrum -lactamase (ESBL) GES-1 was ini-
tially described from a Klebsiella pneumoniae strain in 1998 (5).
Since then, two closely related enzymes, IBC-1 and GES-2,
have also been described (4, 6). A GES-1-producing K. pneu-
moniae strain has been reported from a French hospital, al-
though the patient had just been transferred from French
Guiana, South America. blaGES-1 has also been found in a
Pseudomonas aeruginosa strain isolated in another French
medical center (3) and in K. pneumoniae in Lisbon, Portugal
(2).
The GES-1-producing P. aeruginosa, isolate 48-8896, was
recovered from a 63-year-old female who had a hysterectomy
(Sa˜o Paulo, Brazil) and developed a wound infection while
receiving ceftriaxone, amikacin, and metronidazole. Blood cul-
tures were drawn and were positive for P. aeruginosa. Poly-
myxin B plus vancomycin was started empirically and the in-
fection was eradicated, but the patient died after being
hospitalized in the intensive care unit for 3 months. Isolate
48-8896 showed resistance to imipenem MIC, 8 g/ml),
meropenem (MIC, 8 g/ml), ceftazidime (MIC, 16 g/ml),
cefepime (MIC, 16 g/ml), piperacillin-tazobactam (MIC,
64 g/ml), and all antimicrobial agents evaluated (including
aminoglycosides and quinolones), except for polymyxin B
(MIC, 1 g/ml). Phenotypic detection of ESBL was deter-
mined to be positive using the (ceftazidime/ceftazidime-clavu-
lanic acid and cefepime/cefepime-clavulanic acid) Etest strips
(AB BIODISK, Solna, Sweden).
Since several -lactamase genes are part of gene cassettes
that are class 1 integron mediated and most of them contain an
aminoglycoside acetyltransferase gene cassette, primers lo-
cated in the 5 conserved segment region (5-CS) (5-CCAAG
CTCTCGGGTAACATC-3) and in the flanking region of the
aacA4 gene cassette (5-AACTTGCGAGCGATCCGATG-3)
were used. PCR amplification and subsequent sequencing
analyses of the 1,211-bp PCR product showed a blaGES-1 in the
first position of a class 1 integron (Fig. 1).
The integron harboring blaGES-1 showed a similar adjacent
and upstream context as described in the first report of GES-1
(K. pneumoniae ORI-1) (5). Beyond blaGES-1 was intI1, encod-
ing the integrase of a class 1 integron. Between blaGES-1 and
intI1 was an attI1 site and two promoters (P2 and Pant). How-
ever, the P2 promoter appears to have an absence of three G
residues, and the space between the 35 and 10 sequences is
14 bp (Fig. 1). The secondary promoter (P2) is created by the
insertion of the three Gs, increasing the space between the
35 and 10 regions to 17 bp (1). This evidence suggests that
P2 was probably not contributing to the transcription of
blaGES-1, as previously described in other integrons harboring
this ESBL gene (3, 5). As determined in this study, beyond the
blaGES-1 integron lies a chloramphenicol-acetyltransferase
FIG. 1. Schematic representations of different blaGES-1-containing integrons (a, b, c). The location of the three G residues found in the P2 of
P. aeruginosa 48-8896 is highlighted. The 59 bp are represented with black dots.
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gene cassette, catB8, followed by the 3-CS region of the class
1 integron, which is unique among blaGES-1 genes.
The detection of a GES-1-producing P. aeruginosa isolate in
Latin America (Brazil) was a very worrisome finding, since it
heralds the possibility for the emergence and future dissemina-
tion of new GES derivatives with broader spectrums of hydroly-
ses, such as the carbapenem-hydrolyzing enzyme GES-2 (6).
The SENTRY program was funded by an educational research grant
from Bristol-Myers Squibb.
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